GlassScriptPhysician profile
Franklin Vh Dao
NPI 1174617609
$5,203.73
in general payments reported to CMS, 2019-2025
24 companies · $407 in 2025
The $407 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $784 · 2021: $702 · 2022: $582 · 2023: $948 · 2024: $920 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,274.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,450.44 | 2019-2025 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $673.95 | 2019-2025 | |
| Astellas Pharma US INC | $670.75 | 2021-2025 | Veozah, Myrbetriq |
| Radius Health, INC. | $494.54 | 2019-2023 | Tymlos |
| Abbvie INC. | $484.89 | 2019-2022 | |
| Organon LLC | $214.31 | 2022-2024 | Nexplanon |
| Merck Sharp & Dohme LLC | $210.80 | 2019-2025 | Gardasil 9, Gardasil, Capvaxive |
| Roche Diagnostics Corporation | $149.00 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $102.66 | 2023-2025 | Myfembree, Gemtesa |
| Amarin Pharma, INC. | $102.07 | 2020-2022 | |
| Ethicon US, LLC | $98.65 | 2019-2024 | Monocryl, Ethicon, Stratafix |
| Myriad Women'S Health, INC. | $95.90 | 2023 | Myrisk |
| Exeltis, USA INC. | $91.92 | 2024-2025 | Slynd |
| Covidien LP | $74.07 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $65.39 | 2023 | Seglentis |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $57.63 | 2024-2025 | |
| Therapeuticsmd, INC. | $32.92 | 2022 | |
| Myovant Sciences INC. | $25.65 | 2022 | |
| Evofem Biosciences, INC. | $22.58 | 2022 | |
| Avanos Medical | $22.27 | 2024 | On-Q* Pump and Accessories |
| Exact Sciences Corporation | $21.96 | 2025 | The Cologuard Plus Collection Kit |
| Aspira Women'S Health INC | $15.81 | 2023 | Ova1 |
| Hologic Sales and Service, LLC | $14.42 | 2024 | Myosure Tissue Removal Device |
| Coopersurgical, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Franklin Dao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.